Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy

Patients with severely impaired antibody responses represent a group at-risk in the SARS-CoV-2 pandemic due to the lack of Spike-specific neutralizing antibodies. The main objective of this paper was to assess, by a longitudinal prospective study, COVID-19 infection and mortality rates, and disease...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Cinzia Milito, Francesco Cinetto, Andrea Palladino, Giulia Garzi, Alessandra Punziano, Gianluca Lagnese, Riccardo Scarpa, Marcello Rattazzi, Anna Maria Pesce, Federica Pulvirenti, Giulia Di Napoli, Giuseppe Spadaro, Rita Carsetti, Isabella Quinti
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-04-01
Colecção:	Biomedicines
Assuntos:	COVID-19 SARS-CoV-2 inborn errors of immunity antibody deficiency incidence mortality rate
Acesso em linha:	https://www.mdpi.com/2227-9059/10/5/1026
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!